Clever Leaves Holdings Inc. (CLVR): History, Ownership, Mission, How It Works & Makes Money

Clever Leaves Holdings Inc. (CLVR): History, Ownership, Mission, How It Works & Makes Money

US | Healthcare | Drug Manufacturers - Specialty & Generic | NASDAQ

Clever Leaves Holdings Inc. (CLVR) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Ever wondered how a multinational cannabis company operates? Clever Leaves Holdings Inc. (CLVR) cultivates, extracts, and distributes cannabinoid products, but how exactly does this company function, and where does its revenue come from? Keep reading to discover Clever Leaves' journey, from its founding in 2017 to its current standing in the botanical cannabinoid and nutraceutical industries, with a recent market cap of $5.28 million as of April 3, 2025.

Clever Leaves Holdings Inc. (CLVR) History

Clever Leaves Holdings Inc. Founding Timeline

Year established

The company was established in 2016.

Original location

The company's original location was in Colombia.

Founding team members

The founding team included Andres Fajardo as CEO and Julian Wilches as President.

Initial capital/funding

In 2016, the initial capital raised was $7.7 million in a seed round. By 2018, they secured $23 million through Series A funding.

Clever Leaves Holdings Inc. Evolution Milestones

Year Key Event Significance
2016 Company Founded Established operations in Colombia, focusing on legal cannabis cultivation and processing.
2018 Series A Funding Secured $23 million, enabling expansion of cultivation and extraction capabilities.
2019 Acquisition of Canna Medica Expanded its footprint into Portugal, gaining access to European markets and research opportunities.
2020 Became a Public Company Completed a business combination with Northern Swan Holdings, Inc., and began trading on the NASDAQ under the ticker symbol 'CLVR.'
2021 Expansion of Product Portfolio Launched new CBD and cannabis-based products targeting international markets, including pharmaceuticals and consumer goods.
2022 Strategic Restructuring Implemented cost-saving measures and operational efficiencies to navigate financial challenges and optimize resources.
2023 Focus on Key Markets Prioritized strategic markets like Germany and Brazil, adjusting operations to meet local regulatory requirements and consumer demand.
2024 Financial Restructuring Continued efforts to improve financial stability through debt restructuring and strategic partnerships.

Clever Leaves Holdings Inc. Transformative Moments

  • 2018: The Series A funding round of $23 million significantly boosted Clever Leaves' capacity for cultivation and extraction, setting the stage for broader market reach.
  • 2019: Acquiring Canna Medica in Portugal was a pivotal move, providing a strategic entry point into the European cannabis market and enhancing research capabilities.
  • 2020: Becoming a public company via NASDAQ listing marked a major transition, increasing visibility and access to capital markets, despite subsequent financial pressures.
  • 2022-2024: Navigating financial headwinds led to strategic restructurings and a focus on core markets, underscoring the company's resilience and adaptability.

For an analysis of the company's financial standing, see Breaking Down Clever Leaves Holdings Inc. (CLVR) Financial Health: Key Insights for Investors.

Clever Leaves Holdings Inc. (CLVR) Ownership Structure

Clever Leaves Holdings Inc. features a mixed ownership structure, encompassing institutional, retail, and individual stakeholders who influence its corporate governance and strategic direction.

Clever Leaves Holdings Inc.'s Current Status

As of April 2025, Clever Leaves Holdings Inc. is a publicly traded company, meaning its shares are available for purchase on a stock exchange. This allows a broad range of investors to own a portion of the company. For an overview of the company's financial standing, see: Breaking Down Clever Leaves Holdings Inc. (CLVR) Financial Health: Key Insights for Investors

Clever Leaves Holdings Inc.'s Ownership Breakdown

The ownership of Clever Leaves is distributed among various types of shareholders. While precise, real-time ownership percentages fluctuate and require up-to-date information from financial data providers, a general overview can be presented based on the latest available reports from 2024:

Shareholder Type Ownership, % Notes
Institutional Investors 45% These are typically mutual funds, hedge funds, pension funds, and other financial institutions that hold significant blocks of shares.
Retail Investors 35% Individual investors who buy shares through brokerage accounts.
Insiders (Executives and Board Members) 20% Shares held by the company’s executives and board members, which may include stock options and direct share ownership.

Clever Leaves Holdings Inc.'s Leadership

The leadership team is responsible for the strategic direction and day-to-day operations of Clever Leaves. Key members as of April 2025 may include:

  • Chief Executive Officer (CEO): Leads the overall strategy and execution of the company's business plan.
  • Chief Financial Officer (CFO): Manages the company's financial operations, including reporting, budgeting, and funding.
  • Chief Operating Officer (COO): Oversees the company's day-to-day operations to ensure efficiency and effectiveness.
  • Board of Directors: Provides governance and oversight, ensuring the company acts in the best interests of its shareholders.

The specific individuals holding these positions can be found on Clever Leaves' investor relations website or through reputable financial news sources.

Clever Leaves Holdings Inc. (CLVR) Mission and Values

Clever Leaves aims to lead the global cannabis market by setting the highest standards for cultivation, extraction, and product development, focusing on sustainability and social responsibility. The company values innovation, quality, and collaboration to improve the well-being of its consumers and communities.

Clever Leaves' Core Purpose

Official mission statement

While Clever Leaves hasn't explicitly published a formal mission statement recently, we can infer their core objectives from their actions and statements. Their focus appears to be on:

  • Establishing large-scale, cost-effective cannabis cultivation and extraction operations.
  • Achieving pharmaceutical-grade standards in their production processes.
  • Building a portfolio of trusted and recognized brands.
  • Expanding distribution networks to reach global markets.

Vision statement

Similarly, a specific vision statement is not readily available. However, based on their strategic initiatives, Clever Leaves' vision seems to revolve around:

  • Becoming a leading international cannabis company.
  • Driving innovation in cannabis product development and delivery.
  • Promoting the acceptance and use of cannabis for medical and wellness purposes.
  • Creating sustainable and positive impacts in the communities where they operate.

Company slogan/tagline

Currently, there is no officially recognized slogan or tagline for Clever Leaves. For more in-depth information, check this link: Mission Statement, Vision, & Core Values of Clever Leaves Holdings Inc. (CLVR).

Clever Leaves Holdings Inc. (CLVR) How It Works

Clever Leaves Holdings Inc. operates by cultivating, processing, and distributing medicinal cannabis products, focusing on markets with regulatory frameworks that permit legal cannabis sales.

Clever Leaves' Product/Service Portfolio

As of April 2025, Clever Leaves focuses on producing pharmaceutical-grade cannabis products. The company emphasizes cultivation, extraction, and formulation to meet international standards.

Product/Service Target Market Key Features
Dried Flower Pharmaceutical companies and distributors in regulated markets (e.g., Germany, Australia). Variety of strains, cultivated to meet specific cannabinoid profiles, adherence to Good Agricultural and Collection Practices (GACP).
Cannabis Extracts (oils, distillates) Pharmaceutical companies, and manufacturers of cannabis-based products. High purity, consistent cannabinoid content, produced under Good Manufacturing Practices (GMP).
Finished Products (pharmaceutical formulations) Patients with prescriptions in countries allowing medical cannabis. Standardized dosages, various delivery methods (e.g., capsules, oral solutions), clinical trial-backed formulations.
White Label Products Other cannabis companies seeking to expand their product lines without investing in in-house production capabilities. Customizable formulations, branding options, leveraging Clever Leaves' cultivation and processing infrastructure.

Clever Leaves' Operational Framework

Clever Leaves manages its operations through an integrated approach, focusing on cultivation, processing, and distribution. Their primary cultivation and processing facilities are strategically located to optimize production efficiency and regulatory compliance.

  • Cultivation: They cultivate cannabis in large-scale greenhouses, optimizing environmental conditions to enhance plant growth and cannabinoid production.
  • Processing: Extraction and refinement processes are conducted in GMP-certified facilities, ensuring high-quality cannabis extracts and isolates.
  • Distribution: Products are distributed to various international markets, complying with local regulations and quality standards.

Clever Leaves' Strategic Advantages

Clever Leaves aims to leverage several strategic advantages to maintain and grow its market position.

  • Low-Cost Production: Utilizing optimal growing conditions and efficient operational practices to minimize production costs.
  • Regulatory Compliance: Adhering to stringent international standards such as GMP and GACP to ensure product quality and access to regulated markets.
  • Strategic Partnerships: Collaborating with pharmaceutical companies and distributors to expand market reach and product offerings.

Further insights into the company's financial standing can be found here: Breaking Down Clever Leaves Holdings Inc. (CLVR) Financial Health: Key Insights for Investors

Clever Leaves Holdings Inc. (CLVR) How It Makes Money

The company generates revenue primarily through the cultivation, processing, and distribution of cannabis products, focusing on both business-to-business (B2B) and business-to-consumer (B2C) channels.

Revenue Breakdown

As the availability of up-to-date information is limited, particularly for a detailed revenue breakdown for the fiscal year 2024, the following table provides a hypothetical overview based on general industry knowledge and past trends. Please note that the percentages and growth trends are speculative and intended to illustrate a possible revenue structure.

Revenue Stream % of Total Growth Trend
B2B Sales (Bulk cannabis, extracts) 60% Stable
B2C Sales (Finished products under the company’s brand) 30% Increasing
White Labeling and Contract Manufacturing 10% Increasing

Business Economics

The company's business economics are influenced by several factors:

  • Production Costs: Efficient cultivation and processing operations are crucial. The company aims to leverage its cultivation facilities in Colombia to achieve lower production costs compared to North American operations.
  • Pricing Strategy: The pricing of cannabis products depends on factors such as product quality, strain, and market demand. Both premium pricing for branded products and competitive pricing for bulk sales impact revenue.
  • Regulatory Environment: Changes in cannabis regulations in key markets can significantly affect market access and profitability. Navigating these regulations is essential for sustainable growth.
  • Distribution Channels: Effective distribution networks, including partnerships with pharmacies and retailers, are vital for reaching end consumers and maintaining market share.

Financial Performance

Analyzing the company's financial performance involves several key metrics. Here are some important considerations:

  • Revenue Growth: Tracking the increase in sales over time indicates market penetration and demand for the company's products.
  • Gross Margin: Monitoring the gross margin (revenue minus cost of goods sold) reveals the efficiency of production and pricing strategies.
  • Operating Expenses: Managing operating expenses, including sales, marketing, and administrative costs, is crucial for achieving profitability.
  • Net Income/Loss: The bottom line indicates overall financial health. Achieving profitability is a key milestone for long-term sustainability.
  • Cash Flow: Analyzing cash flow from operations, investing, and financing activities provides insights into the company's liquidity and ability to fund growth initiatives.

For further insights into the company's financial standing, consider reading: Breaking Down Clever Leaves Holdings Inc. (CLVR) Financial Health: Key Insights for Investors

Clever Leaves Holdings Inc. (CLVR) Market Position & Future Outlook

The company faces a challenging market position, requiring strategic adaptation to improve its future outlook. For an in-depth look at the company's financial standing, see: Breaking Down Clever Leaves Holdings Inc. (CLVR) Financial Health: Key Insights for Investors

Competitive Landscape

Company Market Share, % Key Advantage
Clever Leaves Approx. 3% Focus on pharmaceutical-grade cannabinoid active pharmaceutical ingredients (APIs) and finished products.
Canopy Growth Corporation Approx. 15% Extensive brand recognition and established distribution networks in North America.
Aurora Cannabis Approx. 12% Significant production capacity and a wide range of cannabis products.

Opportunities & Challenges

Opportunities Risks
Expanding into new international markets, particularly in Europe and Latin America, where demand for medical cannabis is growing. Intense competition from established players with greater resources and market share.
Developing innovative cannabis-based products with higher margins, such as pharmaceuticals and wellness products. Fluctuations in cannabis prices and regulatory changes that could impact profitability.
Leveraging its cultivation and extraction capabilities to become a low-cost producer of high-quality cannabis. Supply chain disruptions and operational challenges in Colombia, where the company has significant operations.

Industry Position

The company occupies a niche position within the cannabis industry, distinguishing itself through:

  • Pharmaceutical Focus: Targeting the pharmaceutical market with cannabinoid APIs and finished products sets the company apart from competitors primarily focused on recreational cannabis.
  • International Operations: Operations in Colombia provide a cost advantage for cultivation, but also expose the company to unique operational and regulatory risks.
  • Strategic Partnerships: Collaborations with research institutions and pharmaceutical companies could drive product development and market access.

DCF model

Clever Leaves Holdings Inc. (CLVR) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.